Conclusion: Using an aromatase inhibitor rather than tamoxifen in premenopausal women receiving ovarian suppression reduces the risk of breast cancer recurrence. Longer follow-up is needed to assess any impact on breast cancer mortality.
PubMed 35123662 ↗Anastrozole
Also known as Arimidex
The short answer. There isn't much data on Anastrozole yet — 52 mentions, 13 with a clear outcome — so treat these numbers as anecdotal. It is most often used for hormones: 12% of 8 reports say that improved. It is well studied — 94 meta-analyses on PubMed.
From 52 mentions in total — the rest didn't say how it went and aren't counted.
What Anastrozole does, according to users
Of the people who reported each effect, the share who said it got better.
5 more with fewer than 3 reports
What the research says
Systematic reviews and meta-analyses from PubMed, with their published conclusions.
3+ meta-analyses or systematic reviews and 10+ randomized controlled trials in humans. The grade measures how much human research exists — read the conclusions below for what it found. 94 meta-analyses on PubMed ↗ · 312 randomized trials ↗
Conclusion: There is insufficient evidence to support the routine use of Clomiphene, tamoxifen, and aromatase inhibitors to optimise semen parameters in men with infertility. Future randomised trials are needed to confirm the efficacy of clomiphene in improving fertility outcomes in men.
PubMed 39075435 ↗Conclusion: Either steroidal (Testolactone) or nonsteroidal (Anastrozole and Letrozole) aromatase inhibitors were found to statistically improve all the evaluated hormonal and seminal outcomes with a safe tolerability profile. While the evidence is promising, future prospective randomized placebo-controlled multicenter trials are necessary to better define the efficacy of these medications.
PubMed 31621654 ↗Conclusion: In the absence of supportive high-quality evidence, AIs should not be recommended as the first-line pharmacological therapy for infertility in women with PCOS, and further research is needed.
PubMed 22431566 ↗494 human trials on ClinicalTrials.gov test Anastrozole — 232 completed, 72 recruiting now. See all on ClinicalTrials.gov ↗
- ER Reactivation Therapy for Breast Cancer · Metastatic Breast Cancer · 2024
- Brain Blood Flow Responses to Stress: Sex Differences · Cerebrovascular Disorders · 2025
- Neoadjuvant Endocrine Therapy in ER-positive, HER2-negative Early Stage Breast Cancer · Breast Cancer, HER2-negative Breast Cancer · 2026
What government agencies say
Official records from US, Canadian and EU regulators, each linked to its source.
The current US prescription label has no boxed warning.
9 recalls of products named for Anastrozole. Most recent:
- 2022-07-20 · Class II: Lack of Assurance of Sterility record ↗
- 2019-07-17 · Class II: GMP Deviations: Potential cross contamination due to cleaning procedure failure. record ↗
- 2019-06-26 · Class II: CGMP Deviations: Cross Contamination with other products due to CGMP cleaning failure. record ↗
Class I = could cause serious harm; Class II = temporary or reversible harm; Class III = unlikely to cause harm. Recalls are of specific products and lots, not of the ingredient itself. All recalls (openFDA) ↗
36,498 adverse-event reports mention Anastrozole. Most often reported:
- Fatigue · 3,444
- Arthralgia · 3,230
- Nausea · 2,782
- Alopecia · 2,597
- Diarrhoea · 2,388
- Pain · 1,845
Reports often involve several drugs and serious illness; a report doesn't prove the drug caused the problem, and these counts can't tell you how often it happens. Source query (openFDA) ↗
LiverTox rates Anastrozole C — a probable rare cause of liver injury (3–12 published cases). LiverTox entry ↗
NIH has funded 5 research projects with Anastrozole in the title, $10,587,233 in total (2004–2021). NIH RePORTER ↗
Plain-language guides from the US government: MedlinePlus: Anastrozole ↗
Dosage people report
Reported side effects
How often each side effect came up across all reports.
What users say
First-hand experiences, quoted verbatim. We show one positive and one negative where both exist.
“My E2 went up a fuzz last run and anastrazole twice weekly fixed that.”
“Last we checked it was still a bit high (~39 pg/mL I believe), but the breast sensitivity had subsided so he left it.”
“I’ve been taking 0.5mg twice weekly (1mg/week total) for 2 weeks. I am completely crashed”
“I don't use Arimidex pills anymore, I use a volumetric solution because I can dose as little as 0.1mg”
Anastrozole compared
Other options for hormones
Sources
- User reports: 52 mentions in public discussions, quoted with a link to each discussion (e.g. this thread ↗).
- PubMed (US National Library of Medicine, NIH): meta-analyses ↗ · randomized trials ↗
- ClinicalTrials.gov (NIH): registered trials ↗
- FDA drug label (DailyMed) ↗
- FDA adverse-event reports (FAERS) ↗
- FDA recalls ↗
- LiverTox (NIH) ↗
- MedlinePlus (NIH) ↗
- NIH RePORTER ↗
User data from public discussions; research from PubMed. Information only, not medical advice — talk to a doctor before starting, stopping or combining anything. Data updated October 5, 2026. How we rate